Algernon Pharmaceuticals Inc.
AGNPF
$0.06
-$0.003-4.76%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 27.49% | 83.77% | 227.54% | 19.20% | 72.61% |
| Total Depreciation and Amortization | -25.93% | -61.00% | -52.63% | -38.71% | -37.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.09% | -99.73% | -989.27% | -63.92% | -87.32% |
| Change in Net Operating Assets | -70.62% | -178.05% | -891.74% | 61.82% | -14.15% |
| Cash from Operations | -363.19% | -7.49% | -142.60% | 45.48% | 93.60% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 30.95% | 8,607.54% | -152.94% | -- |
| Cash from Investing | -- | 30.95% | 8,607.54% | -152.94% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 249.64% | -99.29% | 5,802.22% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 67.15% | -- | -- | -- |
| Cash from Financing | -- | 127.03% | -99.23% | 1,656.69% | -- |
| Foreign Exchange rate Adjustments | 300.00% | -- | 1,200.00% | 47.37% | -56.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -364.34% | 95.82% | 148.44% | 100.46% | 93.00% |